29/08/2026
GLP-1 medications show promise in arterial disease care.
New research indicates GLP-1 medications are associated with meaningful improvements in PAD patients:
• 26% lower mortality risk
• Up to 48% reduction in amputation rates
• 13% fewer hospitalisations
Dr. Sriram: “Significant research emphasises that weight loss medications can have a major role in preventing progression and complications from arterial disease. Our program of GLP-1 and GIP-based weight loss is structured to ensure controlled, monitored metabolic change that preserves muscle mass at the same time as losing weight."
Read More: https://bit.ly/4gxGvwt
The takeaway: Weight management + supervised exercise + vascular monitoring = comprehensive PAD care.
Individual responses vary significantly. Assessment is essential before treatment.
PAD concerns? Book a vascular assessment.
📞 +65 6472 0503
🔗 vascular.harleystreet.sg